ArticleCureus2026
Clinical Outcomes of Injectable Hyaluronic Acid-Glucosamine Combination in Knee Osteoarthritis: A Saudi Multicenter Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Knee osteoarthritis (OA) remains one of the most common issues causing chronic pain, reduced mobility, and functional limitations in everyday orthopedic practice. Although hyaluronic acid injections are often used for managing symptoms, clinical data regarding injectable hyaluronic acid-glucosamine combination products remain scarce. In this study, we evaluated short- and mid-term clinical outcomes of a single intra-articular hyaluronic acid-glucosamine injection in patients with symptomatic knee OA treated in routine outpatient settings. Methods This multicenter retrospective study included 44 patients with symptomatic knee OA treated in orthopedic outpatient clinics in Riyadh and Jeddah, Saudi Arabia. During routine care, each patient received a single, clinically guided, intra-articular hyaluronic acid-glucosamine injection. Outcomes were assessed using the Lequesne Algofunctional Index and visual analog scale (VAS) pain scores recorded at baseline, approximately six weeks, and six months post-injection. Secondary outcomes included patient satisfaction and treatment-related adverse events. Results Mean Lequesne score decreased from 19.18 ± 3.41 at baseline to 16.36 ± 3.63 at approximately six weeks and 13.28 ± 3.09 at six months based on paired t-test analysis (p < 0.001). Mean VAS pain score decreased from 7.48 ± 1.17 at baseline to 5.73 ± 1.53 at six weeks and 4.21 ± 1.20 at six months (p < 0.001). Most patients reported favorable symptomatic and functional improvement, with an overall mean satisfaction score of 4.21 ± 0.73 out of 5. Reported adverse events were mild and transient, consisting mainly of short-duration post-injection pain and minor local inflammatory reactions. No serious treatment-related adverse events or joint infections were documented. Conclusions In this retrospective cohort, a single intra-articular hyaluronic acid-glucosamine injection was associated with improved pain and functional scores over a six-month follow-up period in patients with symptomatic knee OA. The intervention was generally well tolerated in this routine outpatient cohort. These findings should be interpreted cautiously, given the small sample size and absence of a comparator group.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.